Akebia Therapeutics
AKBA
#6958
Rank
NZ$0.68 B
Marketcap
$3.25
Share price
4.02%
Change (1 day)
110.24%
Change (1 year)

Akebia Therapeutics (AKBA) - P/B ratio

P/B ratio as of November 2024 : -12.0

According to Akebia Therapeutics's latest financial reports the company has a price-to-book ratio of 2.32598.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.

Akebia Therapeutics - P/B ratio (from 2014 to 2024)

P/B ratio by year

Year P/B ratio Change
2024-12-31N/A-100%
2023-12-31-7.64-137.63%
2022-12-3120.3279.87%
2021-12-315.34226.9%
2020-12-311.63-16.1%
2019-12-311.9591.65%
2018-12-311.02-82.27%
2017-12-315.73-2.09%
2016-12-315.8693.66%
2015-12-313.0232.74%
2014-12-312.28
2013-12-31N/A

P/B ratio for similar companies or competitors

Company P/B ratio P/B ratio differencediff. Country
23.3-293.41%๐Ÿ‡บ๐Ÿ‡ธ USA
4.90-140.72%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
5.35-144.53%๐Ÿ‡บ๐Ÿ‡ธ USA
3.20-126.61%๐Ÿ‡บ๐Ÿ‡ธ USA